Comparison of magnetic intensities for mesenchymal stem cell targeting therapy on ischemic myocardial repair: High magnetic intensity improves cell retention but has no additional functional benefit

Cell Transplantation

Volumn 24, Issue 10, 2015, Pages 1981-1997

  Shen, Yunli ^a   Liu, Xuebo ^a   Huang, Zheyong ^b   Pei, Ning ^c   Xu, Jianfeng ^b   Li, Zheng ^b   Wang, Yunkai ^a   Qian, Juying ^b   Ge, Junbo ^b  

^a TONGJI UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI UNIVERSITY   (China)

Author keywords

Magnetic targeting intensity; Mesenchymal stem cells; Microembolization; Myocardial infarction; Rat model

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CAPILLARY DENSITY; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENGRAFTMENT; FLUORESCENCE IMAGING; HEART LEFT VENTRICLE REMODELING; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; IN VITRO STUDY; MAGNETIC FIELD; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CARDIAC MUSCLE; COMPARATIVE STUDY; CYTOLOGY; DISEASE MODEL; HEART LEFT VENTRICLE FUNCTION; MESENCHYMAL STROMA CELL; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; DISEASE MODELS, ANIMAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84943260746     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368914X685302     Document Type: Article

References (36)

1. Bayne, K. Revised Guide for the Care and Use of Laboratory Animals available. American Physiological Society. Physiologist 39:199, 208–211; 1996.
2. Boopathy, A. V.; Pendergrass, K. D.; Che, P. L.; Yoon, Y. S.; Davis, M. E. Oxidative stress-induced Notch1 signaling promotes cardiogenic gene expression in mesenchymal stem cells. Stem Cell Res. Ther. 4:43; 2013.
3. Castro, E.; Mano, J. F. Magnetic force-based tissue engineering and regenerative medicine. J. Biomed. Nanotechnol. 9:1129–1136; 2013.
4. Chaudeurge, A.; Wilhelm, C.; Chen-Tournoux, A.; Farahmand, P.; Bellamy, V.; Autret, G.; Menager, C.; Hagege, A.; Larghero, J.; Gazeau, F.; Clement, O.; Menasche, P. Can magnetic targeting of magnetically labeled circulating cells optimize intramyocardial cell retention? Cell Transplant. 21:679–691; 2012.
5. Cheng, K.; Li, T. S.; Malliaras, K.; Davis, D. R.; Zhang, Y.; Marban, E. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ. Res. 106:1570–1581; 2010.
6. Cheng, K.; Malliaras, K.; Li, T. S.; Sun, B.; Houde, C.; Galang, G.; Smith, J.; Matsushita, N.; Marban, E. Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant. 21:1121–1135; 2012.
7. Clifford, D. M.; Fisher, S. A.; Brunskill, S. J.; Doree, C.; Mathur, A.; Clarke, M. J.; Watt, S. M.; Martin-Rendon, E. Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: Factors that may influence outcomes. PLoS One 7:e37373; 2012.
8. Dawn, B.; Tiwari, S.; Kucia, M. J.; Zuba-Surma, E. K.; Guo, Y.; Sanganalmath, S. K.; Abdel-Latif, A.; Hunt, G.; Vincent, R. J.; Taher, H.; Reed, N. J.; Ratajczak, M. Z.; Bolli, R. Transplantation of bone marrow-derived very small embryonic-like stem cells attenuates left ventricular dysfunction and remodeling after myocardial infarction. Stem Cells 26:1646–1655; 2008.
9. Erwin, G. S.; Crisostomo, P. R.; Wang, Y.; Wang, M.; Markel, T. A.; Guzman, M.; Sando, I. C.; Sharma, R.; Meldrum, D. R. Estradiol-treated mesenchymal stem cells improve myocardial recovery after ischemia. J. Surg. Res. 152:319–324; 2009.
10. Fukushima, S.; Varela-Carver, A.; Coppen, S. R.; Yamahara, K.; Felkin, L. E.; Lee, J.; Barton, P. J.; Terracciano, C. M.; Yacoub, M. H.; Suzuki, K. Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation 115:2254–2261; 2007.
11. Furlani, D.; Ugurlucan, M.; Ong, L.; Bieback, K.; Pittermann, E.; Westien, I.; Wang, W.; Yerebakan, C.; Li, W.; Gaebel, R.; Li, R. K.; Vollmar, B.; Steinhoff, G.; Ma, N. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc. Res. 77:370–376; 2009.
12. Gao, J.; Dennis, J. E.; Muzic, R. F.; Lundberg, M.; Caplan, A. I. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169:12–20; 2001.
13. Grieve, S. M.; Bhindi, R.; Seow, J.; Doyle, A.; Turner, A. J.; Tomka, J.; Lay, W.; Gill, A.; Hunyor, S. N.; Figtree, G. A. Microvascular obstruction by intracoronary delivery of mesenchymal stem cells and quantification of resulting myocardial infarction by cardiac magnetic resonance. Circ. Heart Fail. 3:e5–e6; 2010.
14. Huang, Z.; Pei, N.; Wang, Y.; Xie, X.; Sun, A.; Shen, L.; Zhang, S.; Liu, X.; Zou, Y.; Qian, J.; Ge, J. Deep magnetic capture of magnetically loaded cells for spatially targeted therapeutics. Biomaterials 31:2130–2140; 2010.
15. Huang, Z.; Shen, Y.; Pei, N.; Sun, A.; Xu, J.; Song, Y.; Huang, G.; Sun, X.; Zhang, S.; Qin, Q.; Zhu, H.; Yang, S.; Yang, X.; Zou, Y.; Qian, J.; Ge, J. The effect of nonuniform magnetic targeting of intracoronary-delivering mesenchymal stem cells on coronary embolisation. Biomaterials 34:9905–9916; 2013.
16. Huang, Z.; Shen, Y.; Sun, A.; Huang, G.; Zhu, H.; Huang, B.; Xu, J.; Song, Y.; Pei, N.; Ma, J.; Yang, X.; Zou, Y.; Qian, J.; Ge, J. Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction. Stem Cell Res. Ther. 4:149; 2013.
17. Meluzin, J.; Mayer, J.; Groch, L.; Janousek, S.; Hornacek, I.; Hlinomaz, O.; Kala, P.; Panovsky, R.; Prasek, J.; Kaminek, M.; Stanicek, J.; Klabusay, M.; Koristek, Z.; Navratil, M.; Dusek, L.; Vinklarkova, J. Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: The effect of the dose of transplanted cells on myocardial function. Am. Heart J. 152:975.e9–975.e15; 2006.
18. Molina, E. J.; Palma, J.; Gupta, D.; Gaughan, J. P.; Houser, S.; Macha, M. Right ventricular effects of intracoronary delivery of mesenchymal stem cells (MSC) in an animal model of pressure overload heart failure. Biomed. Pharmacother. 63:767–772; 2009.
19. Molina, E. J.; Palma, J.; Gupta, D.; Torres, D.; Gaughan, J. P.; Houser, S.; Macha, M. Improvement in hemodynamic performance, exercise capacity, inflammatory profile, and left ventricular reverse remodeling after intracoronary delivery of mesenchymal stem cells in an experimental model of pressure overload hypertrophy. J. Thorac. Cardiovasc. Surg. 135:292–299; 2008.
20. Nakamae, T.; Adachi, N.; Kobayashi, T.; Nagata, Y.; Nakasa, T.; Tanaka, N.; Ochi, M. The effect of an external magnetic force on cell adhesion and proliferation of magnetically labeled mesenchymal stem cells. Sports Med. Arthrosc. Rehabil. Ther. Technol. 2:5; 2010.
21. Pfeffer, M. A.; Pfeffer, J. M.; Fishbein, M. C.; Fletcher, P. J.; Spadaro, J.; Kloner, R. A.; Braunwald, E. Myocardial infarct size and ventricular function in rats. Circ. Res. 44:503–512; 1979.
22. Pouzet, B.; Vilquin, J. T.; Hagege, A. A.; Scorsin, M.; Messas, E.; Fiszman, M.; Schwartz, K.; Menasche, P. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann. Thorac. Surg. 71:844–850; discussion 850–851; 2001.
23. Quyyumi, A. A.; Waller, E. K.; Murrow, J.; Esteves, F.; Galt, J.; Oshinski, J.; Lerakis, S.; Sher, S.; Vaughan, D.; Perin, E.; Willerson, J.; Kereiakes, D.; Gersh, B. J.; Gregory, D.; Werner, A.; Moss, T.; Chan, W. S.; Preti, R.; Pecora, A. L. CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. Am. Heart J. 161:98–105; 2011.
24. Robey, T. E.; Saiget, M. K.; Reinecke, H.; Murry, C. E. Systems approaches to preventing transplanted cell death in cardiac repair. J. Mol. Cell. Cardiol. 45:567–581; 2008.
25. Saito, T.; Kuang, J. Q.; Lin, C. C.; Chiu, R. C. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction. J. Thorac. Cardiovasc. Surg. 126:114–123; 2003.
26. Sanganalmath, S. K.; Bolli, R. Cell therapy for heart failure: A comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ. Res. 113:810–834; 2013.
27. Tambara, K.; Sakakibara, Y.; Sakaguchi, G.; Lu, F.; Premaratne, G. U.; Lin, X.; Nishimura, K.; Komeda, M. Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 108(Suppl 1):II259–II263; 2003.
28. Terrovitis, J. V.; Smith, R. R.; Marban, E. Assessment and optimization of cell engraftment after transplantation into the heart. Circ. Res. 106:479–494; 2010.
29. Toma, C.; Wagner, W. R.; Bowry, S.; Schwartz, A.; Villanueva, F. Fate of culture-expanded mesenchymal stem cells in the microvasculature: In vivo observations of cell kinetics. Circ. Res. 104:398–402; 2009.
30. Vulliet, P. R.; Greeley, M.; Halloran, S. M.; MacDonald, K. A.; Kittleson, M. D. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet 363:783–784; 2004.
31. Wang, X.; Jameel, M. N.; Li, Q.; Mansoor, A.; Qiang, X.; Swingen, C.; Panetta, C.; Zhang, J. Stem cells for myocardial repair with use of a transarterial catheter. Circulation 120:S238–S246; 2009.
32. Wohrle, J.; von Scheidt, F.; Schauwecker, P.; Wiesneth, M.; Markovic, S.; Schrezenmeier, H.; Hombach, V.; Rottbauer, W.; Bernhardt, P. Impact of cell number and microvascular obstruction in patients with bone-marrow derived cell therapy: Final results from the randomized, double-blind, placebo controlled intracoronary stem cell therapy in patients with acute myocardial infarction (SCAMI) trial. Clin. Res. Cardiol. 102:765–770; 2013.
33. Wu, J. H.; Wang, H. J.; Tan, Y. Z.; Li, Z. H. Characterization of rat very small embryonic-like stem cells and cardiac repair after cell transplantation for myocardial infarction. Stem Cells Dev. 21:1367–1379; 2012.
34. Xu, J.; Qian, J.; Xie, X.; Lin, L.; Zou, Y.; Fu, M.; Huang, Z.; Zhang, G.; Su, Y.; Ge, J. High density lipoprotein protects mesenchymal stem cells from oxidative stress-induced apoptosis via activation of the PI3K/Akt pathway and suppression of reactive oxygen species. Int. J. Mol. Sci. 13:17104–17120; 2012.
35. Yao, K.; Huang, R.; Sun, A.; Qian, J.; Liu, X.; Ge, L.; Zhang, Y.; Zhang, S.; Niu, Y.; Wang, Q.; Zou, Y.; Ge, J. Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction. Eur. J. Heart Fail. 11:691–698; 2009.
36. Zhang, C.; Liu, T.; Su, Y.; Luo, S.; Zhu, Y.; Tan, X.; Fan, S.; Zhang, L.; Zhou, Y.; Cheng, T.; Shi, C. A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging. Biomaterials 31:6612–6617; 2010.